<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 07-Sep-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (07-Sep-2025)</h1>
<hr />
<h2>Top News Highlights</h2>
<ul>
<li><strong>Major Immigration Actions</strong>: Over 300 South Koreans detained at a Hyundai plant in Georgia are being released; ICE surges underway in Boston and Massachusetts, ramping up immigration enforcement efforts.</li>
<li><strong>Ukraine Escalation</strong>: Largest Russian airstrike of the war hits Ukrainian cabinet building, escalating geopolitical and energy risks in Europe.</li>
<li><strong>Leadership Shifts in Japan</strong>: Prime Minister Ishiba resigns following major election losses, adding volatility to Japanese markets and impacting the yen outlook.</li>
<li><strong>US Politics &amp; Policy</strong>: Trump administration threatens a federal crackdown in Chicago and continues to be a major force in shaping both federal immigration and economic policy. The &quot;Project 2025&quot; group calls for aggressive US birth-rate policies.</li>
<li><strong>Disruptions</strong>: Red Sea undersea cable cuts are causing widespread internet outages in the Middle East and South Asia, impacting Microsoft Azure and broader digital infrastructure.</li>
<li><strong>US Jobs Report Weakness</strong>: A disappointing jobs report sparks market/media backlash, raising the profile of recession risk and labor market stress.</li>
<li><strong>SpaceX</strong>: Successful Starlink satellite launch from California, pushing its satellite internet footprint past 2,000 satellites.</li>
<li><strong>AI Risks</strong>: &quot;Godfather of AI&quot; warns of major unemployment spikes and capital concentration due to advancing AI capabilities.</li>
<li><strong>WHO Updates</strong>: GLP-1 diabetes treatments (Ozempic, Mounjaro) added to the essential medicines list, spotlighting shifts in pharma/biotech landscape and global healthcare priorities.</li>
</ul>
<hr />
<h2>Macroeconomic and Geopolitical Outlook</h2>
<h3>US Economy &amp; Fed Policy</h3>
<ul>
<li><strong>Inflation</strong>: Both headline and core inflation are likely to hover above 3% for the rest of 2025, even approaching 4% at some points. This suggests persistent pricing pressures despite a relatively stable near-term growth outlook.</li>
<li><strong>GDP &amp; Recession Risk</strong>: GDP is expected to remain positive, but below 2% for 2025. The probability of a recession beginning in 2025 is very low, but global indicators (IMF warnings, disappointing US jobs data) remain areas to watch for unexpected shocks.</li>
<li><strong>Labor Market</strong>: Unemployment is now well above 4% and expected to continue rising, potentially straining consumer spending and reducing corporate pricing power over the next year.</li>
<li><strong>Fed Path</strong>: Rate cuts are on track for late 2025, with incremental easing (mostly in 25 bps steps) likely. No meaningful chance of hikes, and aggressive cuts are only plausible in case of a sharp economic reversal.</li>
<li><strong>Long Rates &amp; Dollar</strong>: 10-year yields are likely to dip below 4%, though a dramatic move below 3.5% appears unlikely barring crisis. The dollar is expected to weaken somewhat, especially if inflation persists while treasury yields trend lower.</li>
</ul>
<h3>US Fiscal &amp; Political Policy</h3>
<ul>
<li><strong>Debt &amp; Budget</strong>: US national debt will push above $38T by year-end, with no credible spending cuts expected despite rhetoric. Tariffs may generate significant incremental revenue, but will also raise the risk of trade retaliation.</li>
<li><strong>Tariffs/Trade</strong>: Incoming US trade policy is likely to target key manufacturing countries (China, South Korea, Japan, Germany, Taiwan, Mexico, Canada), with high odds of new tariffs on semiconductors, copper, and possibly pharma.</li>
<li><strong>Healthcare</strong>: Major legislative changes (e.g., full Obamacare repeal or strong measures against pharma monopolies) are unlikely before 2027, but price controls and essential-medicine access are rising themes.</li>
</ul>
<h3>Geopolitical Risks</h3>
<ul>
<li><strong>Ukraine War/Energy</strong>: Fresh escalation in Ukraine increases energy/commodity risk, especially in Europe. Watch for secondary effects on global defense sector and commodity prices.</li>
<li><strong>Japan</strong>: Political transition after Ishiba's resignation could trigger currency/volatility shocks (especially with elevated earthquake odds), and may lead to new economic or monetary policy directions.</li>
<li><strong>EU Disintegration</strong>: The probability of an EU member leaving, or a major country like France holding a referendum, is notable but still below levels suggesting full crisis.</li>
</ul>
<h3>Climate &amp; Natural Disaster</h3>
<ul>
<li><strong>Earthquake Risk</strong>: Elevated earthquake risk in Japan (before 2030) and moderate risk in California introduces risk for JPY, real estate, infrastructure, and insurance exposures.</li>
<li><strong>Energy Transition</strong>: No realistic path to renewables being the world’s primary energy source by 2030; coal, oil, and gas will still dominate, with slow incremental renewable gain.</li>
</ul>
<hr />
<h2>Sector and Thematic Implications</h2>
<h3>Technology &amp; AI</h3>
<ul>
<li><strong>IPO Market</strong>: A backlog of anticipated tech IPOs (Ramp, Klarna, OpenAI, Stripe, Starlink, SpaceX) exists, but short-term activity is likely limited. Ramp and Klarna are most likely among private fintechs to go public first.</li>
<li><strong>AI Regulation</strong>: Companies like OpenAI face meaningful legal and compliance risks (copyright cases, multimillion-dollar tort claims). Congress may ban certain AI providers (e.g., DeepSeek) on government networks. Expect growing antitrust scrutiny across all major tech players (Alphabet, Microsoft, Amazon, Meta, Tesla).</li>
<li><strong>AI &amp; Labor</strong>: Warnings about AI-driven unemployment are building—a potential source of labor dislocation, long-run margin expansion for select tech leaders, but increasing regulatory risk/wealth concentration concerns.</li>
<li><strong>Cyber Risks</strong>: Internet infrastructure disruption (Red Sea cables) underscores ongoing vulnerability and highlights business continuity and security exposures for digital infrastructure providers—potential tailwinds for satellite connectivity (Starlink) and cybersecurity names.</li>
</ul>
<h3>Energy &amp; Commodities</h3>
<ul>
<li><strong>Oil &amp; Gas</strong>: WTI oil is more likely to remain under pressure (below $65) than spike dramatically, with a possibility of significant volatility mostly due to geopolitics rather than demand. Natural gas prices expected to remain strong.</li>
<li><strong>Copper &amp; Semiconductors</strong>: Potential US tariffs on copper and semiconductor imports could create winners and losers within the mining and tech supply chain; expect commodity price volatility.</li>
<li><strong>Solar/Renewables</strong>: While substantial new US solar capacity is expected, it won’t overtake fossil fuels for base-load supply in the medium term.</li>
</ul>
<h3>Financials</h3>
<ul>
<li><strong>ETFs &amp; Asset Managers</strong>: Major flows and rising AUM (BlackRock), with ongoing performance fee and digital asset pillars. Anticipate continued growth in ETF adoption and strong private market fundraising. Watch for any margin compression if fee wars intensify.</li>
<li><strong>Rates &amp; Bonds</strong>: Persistent inflation but moderating yields point to opportunities in intermediate-duration treasuries, TIPS, and inflation-protected assets.</li>
</ul>
<h3>Healthcare</h3>
<ul>
<li><strong>Pharma</strong>: Pricing and access themes intensifying—WHO’s inclusion of GLP-1 drugs boosts their global profile; US legislative risk against monopolistic practices persists but not immediate.</li>
<li><strong>Biotech</strong>: Type 1 diabetes cure unlikely to be approved soon, keeping focus on chronic management and innovation.</li>
</ul>
<h3>Real Estate, REITs &amp; Insurance</h3>
<ul>
<li><strong>Risk Sensitivity</strong>: West Coast (California, LA) and Japanese REITs/insurers face tail risks from earthquakes and political/FX shocks.</li>
</ul>
<h3>Consumer/Media</h3>
<ul>
<li><strong>Streaming and Content</strong>: Media properties (Disney, Spotify) have strong franchises, but face continual churn in hit-driven environments. &quot;The Simpsons&quot; ending is plausible within a few years, impacting content portfolios.</li>
<li><strong>Cannabis Law</strong>: Moderate chance of US cannabis (weed) rescheduling, with implications for consumer, healthcare and retail-oriented REITs/exposures.</li>
</ul>
<hr />
<h2>Individual Equities Outlook</h2>
<ul>
<li><strong>NVIDIA</strong>: Strong likelihood to continue as the market cap leader globally, backed by AI demand and strong sector tailwinds.</li>
<li><strong>Apple</strong>: Leadership change is not expected soon; hardware pipeline remains robust with incremental product excitement (AirPods, iPhone 17) enhancing stickiness rather than transforming the narrative.</li>
<li><strong>Amazon &amp; Apple</strong>: Both face elevated risk of being found in violation of monopoly/antitrust provisions before end of decade, increasing regulatory/event risk.</li>
<li><strong>Oracle</strong>: Consistent strategy focused on cloud infrastructure, remaining performance obligations, multicloud and AI contracts. Investors should pay attention to capital expenditures and cloud growth guideposts.</li>
<li><strong>Tesla, Microsoft, Alphabet, Meta</strong>: Next in line for heightened antitrust/FTC scrutiny—possible sector-wide pressure on business practices, especially with Big Tech dominance narrative persisting.</li>
</ul>
<hr />
<h2>Tactical Investor Guidance</h2>
<ul>
<li>Stay selective in tech/AI, favoring entrenched leaders well-positioned for regulatory dialogue.</li>
<li>Prepare for higher inflation/low but not collapsing long yields; overweight TIPS/intermediate debt.</li>
<li>Monitor policy shifts in US tariffs/trade for implications on supply chains, inflation, industrials and multinational consumer companies.</li>
<li>Keep exposure to insurance, commodities, infra-REITs risk-adjusted for catastrophe/disaster (calculated tail risk for Japan/California).</li>
<li>Recession risk is muted but rising unemployment and labor pressure will weigh on consumer cyclical names; resilience in services, healthcare, and digital infrastructure is preferable.</li>
<li>Be vigilant for event-driven volatility on the back of regulatory, M&amp;A, and macro shocks (Ukraine conflict, Japan volatility, China growth trajectory, US policy).</li>
</ul>
<hr />
<p><strong>Immediate Watchlist</strong>: NVDA, AAPL, AMZN, MSFT, ORCL, BLK, major industrial/commodity exporters, insurance/REITs with Japan/California/West Coast risk, semiconductors &amp; key mining plays, and regulated healthcare names (especially GLP-1/diabetes innovation leaders). Crypto and ETF exposure remains a tactical satellite, not core.</p>
<hr />

</main>
</body>
</html>
